A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

C.A. Rentsch; G.N. Thalmann; I. Lucca; M. Kwiatkowski; G.J. Wirth; R.T. Strebel; D. Engeler; A. Pedrazzini; C. Hüttenbrink; W. Schultze-Seemann; R. Torpai; L. Bubendorf; A. Wicki; B. Roth; P. Bosshard; H. Püschel; D.T. Boll; L. Hefermehl; F. Roghmann; M. Gierth; K. Ribi; S. Schäfer; S. Hayoz

A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

C.A. Rentsch, G.N. Thalmann, I. Lucca, M. Kwiatkowski, G.J. Wirth, R.T. Strebel, D. Engeler, A. Pedrazzini, C. Hüttenbrink, W. Schultze-Seemann, R. Torpai, L. Bubendorf, A. Wicki, B. Roth, P. Bosshard, H. Püschel, D.T. Boll, L. Hefermehl, F. Roghmann, M. GierthK. Ribi, S. Schäfer, S. Hayoz

Careum Hochschule Gesundheit

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	195-202
Seitenumfang	8
Fachzeitschrift	European urology oncology
Jahrgang	5
Ausgabenummer	2
Publikationsstatus	Veröffentlicht - 2022

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Dieses zitieren

Rentsch, C. A., Thalmann, G. N., Lucca, I., Kwiatkowski, M., Wirth, G. J., Strebel, R. T., Engeler, D., Pedrazzini, A., Hüttenbrink, C., Schultze-Seemann, W., Torpai, R., Bubendorf, L., Wicki, A., Roth, B., Bosshard, P., Püschel, H., Boll, D. T., Hefermehl, L., Roghmann, F., ... Hayoz, S. (2022). A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14. European urology oncology, 5(2), 195-202.

@article{7914da1de90f4d1fb7a974f16cf1dd12,

title = "A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Gu{\'e}rin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14",

author = "C.A. Rentsch and G.N. Thalmann and I. Lucca and M. Kwiatkowski and G.J. Wirth and R.T. Strebel and D. Engeler and A. Pedrazzini and C. H{\"u}ttenbrink and W. Schultze-Seemann and R. Torpai and L. Bubendorf and A. Wicki and B. Roth and P. Bosshard and H. P{\"u}schel and D.T. Boll and L. Hefermehl and F. Roghmann and M. Gierth and K. Ribi and S. Sch{\"a}fer and S. Hayoz",

year = "2022",

language = "English",

volume = "5",

pages = "195--202",

journal = "European urology oncology",

number = "2",

}

Rentsch, CA, Thalmann, GN, Lucca, I, Kwiatkowski, M, Wirth, GJ, Strebel, RT, Engeler, D, Pedrazzini, A, Hüttenbrink, C, Schultze-Seemann, W, Torpai, R, Bubendorf, L, Wicki, A, Roth, B, Bosshard, P, Püschel, H, Boll, DT, Hefermehl, L, Roghmann, F, Gierth, M, Ribi, K, Schäfer, S & Hayoz, S 2022, 'A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14', European urology oncology, Jg. 5, Nr. 2, S. 195-202.

A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14. / Rentsch, C.A.; Thalmann, G.N.; Lucca, I. et al.
in: European urology oncology, Jahrgang 5, Nr. 2, 2022, S. 195-202.

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

TY - JOUR

T1 - A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non-muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14

AU - Rentsch, C.A.

AU - Thalmann, G.N.

AU - Lucca, I.

AU - Kwiatkowski, M.

AU - Wirth, G.J.

AU - Strebel, R.T.

AU - Engeler, D.

AU - Pedrazzini, A.

AU - Hüttenbrink, C.

AU - Schultze-Seemann, W.

AU - Torpai, R.

AU - Bubendorf, L.

AU - Wicki, A.

AU - Roth, B.

AU - Bosshard, P.

AU - Püschel, H.

AU - Boll, D.T.

AU - Hefermehl, L.

AU - Roghmann, F.

AU - Gierth, M.

AU - Ribi, K.

AU - Schäfer, S.

AU - Hayoz, S.

PY - 2022

Y1 - 2022

M3 - Article

VL - 5

SP - 195

EP - 202

JO - European urology oncology

JF - European urology oncology

IS - 2

ER -